Shannon Reaney, Ph.D., is a seasoned patent attorney with over 20 years of experience specializing in life sciences intellectual property law. As chair of the firm’s 100+ person Patent Strategy + Prosecution practice and co-chair of the cross-disciplinary Intellectual Property Group, Shannon provides strategic patent counsel to pharmaceutical, biotechnology, cosmetics, and agricultural companies worldwide. She excels in patent portfolio development, prosecution, and management, helping innovators protect and maximize the value of their intellectual property assets.
Shannon’s advanced scientific training and extensive legal experience enable her to deliver comprehensive patent strategy and prosecution services across a broad spectrum of life sciences technologies, including:
In addition to her extensive experience in patent strategy and prosecution, Shannon is highly regarded for her work in:
Shannon received her Ph.D. in chemistry from the University of California, Santa Cruz, where her doctoral research concentrated on synthetic organic methodology and the use of lithium aminoborohydrides in novel hydride and amine transfer reactions. She received her B.A. in biochemistry from Occidental College, where she conducted undergraduate research investigating psoralen-DNA intercalation.
Shannon has authored several first-author publications in peer-reviewed journals and presented her research at major conferences, including those sponsored by the American Chemical Society and the IUPAC World Chemistry Congress.
Genentech
Patent counsel to Genentech in securing valuable patent term extension for numerous approved biologic and small molecule products and assisting the client with numerous IP diligence evaluations for potential investment or licensing opportunitie
Tessera Therapeutics
Providing strategic patent counseling and prosecution services to Tessera Therapeutics, whose genome engineering technology and proprietary lipid nanoparticles potentially have significant medicinal applications to address major unmet medical needs.
Maze Therapeutics
Patent counsel to Maze Therapeutics, Inc. on all aspects of patent strategy and portfolio development for the company’s small molecule programs, including the investigational product MZE001, which was granted Orphan Drug Designation for the treatment of Pompe disease and for which Maze entered into an exclusive worldwide license agreement with Shionogi & Co., Ltd.
Nuvation Bio, Inc.
Nuvation Bio, Inc., a global oncology company focused on tackling some of the toughest challenges in cancer treatment, has relied on Shannon for patent strategy and advice for protecting its product candidates in development and in assisting the company with IP due diligence in assessing strategic acquisition and licensing opportunities, including its acquisition of AnHeart Therapeutics.
Pliant Therapeutics
Patent counsel to Pliant Therapeutics, a clinical-stage biopharmaceutical company focused on developing therapies for fibrotic disease, including idiopathic pulmonary fibrosis (IPF) and primary sclerosing cholangitis (PSC).
Cerus Corporation
Cerus Corporation, a biotechnology company specializing in blood safety technologies, has long relied on Morrison Foerster for overall patent strategy, including patent application drafting and prosecution. Shannon leads the team that supports Cerus in protecting its commercial and development technologies.
Recommended for Intellectual Property: Patents: Prosecution
The Legal 500 US 2025
Recognized as "Patent Star"
Managing Intellectual Property 2024-2025
Life Sciences Star in USA – Nationwide: Patent Prosecution, Patent Strategy & Management
LMG 2025